Learn

The "Medicinal Cannabis: COPD, Asthma, Eczema, Psoriasis, and Skin Conditions" course is an in-depth exploration of how cannabinoid therapy can address chronic inflammatory and immune-related conditions. Divided into six units, the course offers detailed knowledge and practical strategies for using medicinal cannabis in clinical practice. Each unit focuses on specific conditions, discussing pathophysiology, conventional treatments, and the emerging role of cannabinoids.

Unit 1: Introduction to Skin Conditions
Explore the foundational role of the cutaneous endocannabinoid system in regulating skin health. Learn about the mechanisms through which cannabinoids interact with CB1 and CB2 receptors to manage inflammation, immune response, and cellular balance in the skin. The unit provides an overview of systemic and topical applications of THC and CBD for skin health.

Unit 2: Acne Vulgaris
This unit examines the endocannabinoid system's impact on sebaceous gland activity and keratinocyte regulation. Discover how cannabinoids like CBD and THC can modulate sebum production, reduce inflammation, and address the root causes of acne, providing a potential alternative to conventional treatments.

Unit 3: Atopic Dermatitis (Eczema)
Understand the chronic inflammatory nature of eczema and its link to endocannabinoid system dysregulation. Learn how cannabinoids can help reduce pruritus (itch), inflammation, and immune dysregulation, offering relief through systemic or topical therapies.

Unit 4: Psoriasis and Pruritus
This unit delves into the autoimmune aspects of psoriasis, highlighting how cannabinoids inhibit keratinocyte overproduction and modulate cytokine activity. Explore the dual role of cannabinoids in reducing inflammation and alleviating itch, a common symptom across various skin conditions.

Unit 5: Skin Cancer and Scleroderma
Discover the adjunctive potential of cannabinoids in managing non-melanoma skin cancers and the fibrotic condition of scleroderma. Learn how cannabinoids can induce apoptosis in abnormal cells, inhibit angiogenesis, and modulate immune responses, complementing conventional surgical and medical treatments.

Unit 6: Pulmonary Conditions
This final unit focuses on COPD and asthma, exploring how cannabinoids like THC can act as bronchodilators and reduce airway inflammation. Emphasis is placed on safe administration methods, such as vaporisation, to maximise therapeutic effects while minimising adverse outcomes.

This course combines evidence-based insights with practical applications, offering interactive case discussions, recommended readings, and assessment options to enhance your understanding. Expand your professional expertise and empower your patients with innovative cannabinoid therapies.

Learning Outcomes

1. Evaluate medicinal cannabis treatment options for COPD, asthma and systemic conditions.
2. Assess topical cannabinoid therapy for eczema, psoriasis and skin conditions.

Details

Cost: $195

Suitable for: All degree qualified medical practitioners.

Study mode: 100% online

Disclaimer: Please note, once you click 'Register now' you will be leaving the AMA’s CPD Home website and entering a third-party education provider’s website. If you choose to register for this learning, you will need to provide some of your personal information directly to the third-party education provider. If you have any queries about how third-party education providers use, disclose or store your personal information you should consult their privacy policy.

Upon completion, your CPD activity record may take up to 4 weeks to be reflected on your CPD Home Dashboard.